CN Patent
CN1351495A — 用于改善药物保留的脂质体组合物
Assigned to Alza Corp · Expires 2002-05-29 · 24y expired
What this patent protects
本发明描述了用于增强喹诺酮化合物、特别是氟喹诺酮化合物的保留的脂质体组合物。脂质体中包载的是能有效地与氟喹诺酮形成配合物的多阴离子聚合物。还描述了这类脂质体的制备方法,该方法包括除去未被包载的多阴离子聚合物的过程。
USPTO Abstract
本发明描述了用于增强喹诺酮化合物、特别是氟喹诺酮化合物的保留的脂质体组合物。脂质体中包载的是能有效地与氟喹诺酮形成配合物的多阴离子聚合物。还描述了这类脂质体的制备方法,该方法包括除去未被包载的多阴离子聚合物的过程。
Drugs covered by this patent
- Camptosar (Irinotecan Hydrochloride) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.